GTC offers CGP of DNA/RNA for solid/hematologic malignancies + Liquid Trace an LBx that analyses cfDNA and cfRNA.
We have a fast TAT of 5-10 days and a QNS rate of <1%. Our cooperative model allows us to partner with laboratories, hospitals, and others to share resources which create efficiencies in cost and quality. GTC’s testing is covered by Medicare.